State Auto Financial Corp. (STFC) is Trading Lower on Unusual Volume for December 21

Equities Staff |

State Auto Financial Corp. (STFC) experienced unusually high volume on Dec. 21, as the stock lost 0.39% to a closing price of $20.50. The stock saw 110,263 shares trade hands over the course of the day on 352 trades. Given that the stock’s average daily volume over the last month has been 29,276 shares a day, this represents a pretty substantial spike over the norm.

State Auto Financial Corp. has a P/B ratio of 0.97. It also has a P/E ratio of 7.5. The stock has traded between $27.37 and $20.01 over the last 52-weeks, its 50-day SMA is now $23.48, and its 200-day SMA $23.52.

State Auto Financial Corp is a property and casualty insurance holding company. It is engaged in writing both personal and business lines of insurance.

Headquartered in Columbus, OH, State Auto Financial Corp. has 2,274 employees and is currently under the leadership of CEO Michael E. Larocco.

For a complete fundamental analysis analysis of State Auto Financial Corp., check out’s Stock Valuation Analysis report for STFC. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets


A peer-to-Peer authentic photo marketplace disrupting the $10B commercial photography industry.

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…